priti10 created a new article
42 w

Regulatory Landscape and Challenges in the Biosimilars Market | # Biosimilars Market Demand # Biosimilars Market Trends # Biosimilars Market Forecast

Regulatory Landscape and Challenges in the Biosimilars Market

Regulatory Landscape and Challenges in the Biosimilars Market

Biosimilars cost less because the path to their approval is shorter and cheaper. Manufacturers do not need to go through the same number of clinical trials and spend as much on research and development as biologics.